Prediction of postoperative decompensated liver function by technetium-99m galactosyl-human serum albumin liver scintigraphy in patients with hepatocellular carcinoma complicating chronic liver disease

British Journal of Surgery

Volumn 84, Issue 6, 1997, Pages 793-796

  Kim, Y K ^a   Nakano, H ^a   Yamaguchi, M ^a   Kumada, K ^a   Takeuchi, S ^a   Kitamura, N ^a   Takahashi, H ^a   Hasebe, S ^a   Midorikawa, T ^a   Sanada, Y ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LIVER CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SCINTIGRAPHY;

AGED; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; HEPATITIS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 8244255005     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840616     Document Type: Article

References (23)

1. Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE. Liver resection of metastatic colorectal cancer. Surgery 1986; 100: 804-10.
2. Nagasue N, Kohno H, Chang YC et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217: 375-84.
3. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29.
4. Noguchi T, Imai T, Mizumoto R. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology 1990; 37: 165-71.
5. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-51.
6. Franco D, Smadja C, Meakins JL, Wu A, Berthoux L, Grange D. Improved early results of elective hepatic resection for liver tumors. One hundred consecutive hepatectomies in cirrhotic and noncirrhotic patients. Arch Surg 1989; 124: 1033-7.
7. Pricer WE Jr, Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J Biol Chem 1971; 246: 4825-33.
8. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984; 87: 1217-21.
9. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage. Am J Gastroenterol 1992; 87: 865-70.
10. Makuuchi M, Kosuge T, Takayama T et al. Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304.
11. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology 1993; 17: 814-19.
12. Lui W-Y, Chau G-Y, Loong C-C et al. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma. Arch Surg 1995; 130: 1090-7.
13. Yamanaka N, Okamoto E, Kuwata K, Tanaka N. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984; 200: 658-63.
14. Miyagawa S, Makuuch M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995; 169: 589-94.
15. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. Radiology 1984; 151: 191-6.
16. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m-galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding. J Nucl Med 1984; 25: 779-87.
17. Kwon A-H, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 1995; 117: 429-34.
18. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 43-57.
19. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962; 41: 1169-79.
20. Ashwell G, Steer CJ. Hepatic recognition and catabolism of serum glycoproteins. JAMA 1981; 246: 2358-64.
21. Stockert RJ, Morell AG. Hepatic binding protein: the galactose-specific receptor of mammalian hepatocytes. Hepatology 1983; 3: 750-7.
22. Sawamura T, Kawasato S, Tsuda M, Naitoh Y, Shiozaki Y, Sameshima Y. Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma. Gastroenterol Jpn 1985; 20: 201-8.
23. Kokudo N, Nozawa M, Takahashi S et al. Quantitative estimation of intrasplenically transplanted hepatocytes in Gunn rats using technetium-99m-diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin. Transplantation 1995; 60: 200-2.